TY - JOUR
T1 - World sleep society international sleep medicine guidelines position statement endorsement of “behavioral and psychological treatments for chronic insomnia disorder in adults
T2 - An American Academy of sleep medicine clinical practice guidelines”
AU - Morin, Charles M.
AU - Bei, Bei
AU - Bjorvatn, Bjørn
AU - Poyares, Dalva
AU - Spiegelhalder, Kai
AU - Wing, Yun Kwok
AU - on behalf of the Governing Council of the World Sleep Society
N1 - Funding Information:
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Charles Morin received research grants from Eisai, Idorsia, and Lallemand Health; served as consultants for Eisai and Idorsia; and received royalties from Mapi Research Trust, all outside the submitted work. Bjørn Bjorvatn served as consultant for F. Hoffmann-La Roche Ltd and received payment for lectures from AGB-Pharma AB, all outside the submitted work. YKWing received personal fees from Eisai Co., Ltd for lecture, travel support from Lundbeck HK Limited, which were outside the submitted work. Kai Spiegelhalder, Bei Bei, and Dalva Poyares declared no conflict of interest.
Publisher Copyright:
© 2023
PY - 2023/9
Y1 - 2023/9
N2 - This paper summarizes the position statement of the World Sleep Society (WSS) International Guidelines Committee regarding the Clinical Practice Guidelines on the Behavioral and Psychological Treatments for Chronic Insomnia Disorder in Adults prepared by a task force of the American Academy of Sleep Medicine (AASM). The practice guidelines were reviewed for their relevance and applicability to the practice of sleep medicine around the world. The WSS Work Group endorsed the AASM strong recommendation for Multicomponent Cognitive Behavioral Therapy as the treatment of choice for Insomnia Disorder and conditional endorsement for its single-therapy components (sleep restriction, stimulus control, relaxation); use of sleep hygiene education as single therapy was not endorsed due to lack of evidence for its efficacy. The strong recommendation for multicomponent CBT-I applied to patients with chronic insomnia disorder with or without comorbid psychiatric and medical conditions. Main caveats with regard to CBT-I remains the lack of adequately trained therapists and variability in terms of training available in different parts of the world. Unanswered questions about the applicability, availability, accessibility and potential sociodemographic (age, sex, ethnicity, regions) moderators of treatment outcomes were discussed. Despite growing evidence documenting the benefits of digital CBT-I, individual, in-person CBT-I delivered by a trained professional (mental health) provider is regarded as the optimal method to deliver CBT-I.
AB - This paper summarizes the position statement of the World Sleep Society (WSS) International Guidelines Committee regarding the Clinical Practice Guidelines on the Behavioral and Psychological Treatments for Chronic Insomnia Disorder in Adults prepared by a task force of the American Academy of Sleep Medicine (AASM). The practice guidelines were reviewed for their relevance and applicability to the practice of sleep medicine around the world. The WSS Work Group endorsed the AASM strong recommendation for Multicomponent Cognitive Behavioral Therapy as the treatment of choice for Insomnia Disorder and conditional endorsement for its single-therapy components (sleep restriction, stimulus control, relaxation); use of sleep hygiene education as single therapy was not endorsed due to lack of evidence for its efficacy. The strong recommendation for multicomponent CBT-I applied to patients with chronic insomnia disorder with or without comorbid psychiatric and medical conditions. Main caveats with regard to CBT-I remains the lack of adequately trained therapists and variability in terms of training available in different parts of the world. Unanswered questions about the applicability, availability, accessibility and potential sociodemographic (age, sex, ethnicity, regions) moderators of treatment outcomes were discussed. Despite growing evidence documenting the benefits of digital CBT-I, individual, in-person CBT-I delivered by a trained professional (mental health) provider is regarded as the optimal method to deliver CBT-I.
UR - http://www.scopus.com/inward/record.url?scp=85165281169&partnerID=8YFLogxK
U2 - 10.1016/j.sleep.2023.07.001
DO - 10.1016/j.sleep.2023.07.001
M3 - Review Article
C2 - 37454606
AN - SCOPUS:85165281169
SN - 1389-9457
VL - 109
SP - 164
EP - 169
JO - Sleep Medicine
JF - Sleep Medicine
ER -